Aveanna Healthcare Holdings Announces First Quarter 2023 Financial Results
May 11, 2023
Revenue increased 3.5% to $466.4 million, compared to Q1 2022 Gross margin decreased 0.2% to $144.5 million, compared to Q1 2022 Net loss was $32.0 million, compared to net income of $25.3 million in Q1 2022 Adjusted EBITDA decreased 25.0% to $28.5 million, compared to Q1 2022 Affirms previously
Read More
Aveanna Announces First Quarter 2023 Earnings Release Date and Conference Call
April 24, 2023
ATLANTA, April 24, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 11, 2023, to be followed by a conference call at 10:00 a.m.
Read More
Aveanna Healthcare Holdings Announces Fourth Quarter and Full Year 2022 Financial Results
March 16, 2023
Revenue increased 9.0% to $451.1 million, compared to Q4 2021 Gross margin increased 3.5% to $128.8 million, compared to Q4 2021 Net loss was $237.8 million, compared to net loss of $126.2 million in Q4 2021 Adjusted EBITDA decreased 35% to $29.7 million, compared to Q4 2021 ATLANTA, March 16, 2023
Read More
Aveanna Announces Fourth Quarter and Full Year 2022 Earnings Release Date and Conference Call
February 27, 2023
ATLANTA, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 16, 2023, to be followed by a conference call at 10 a.m.
Read More